2018 / 06

Next Paper
DOI: 10.24075/brsmu.2018.084

ORIGINAL RESEARCH

Nanoparticles guided precise transplantation of varying numbers of mesenchymal stem cells into post–traumatic syrinx in spinal cord injury rat

Zhang C1,2,3,4, Morozova AYu4, Baklaushev VP3, Gubsky IL2, Melnikov PA4, Gabashvily AN6, Wang G1, Li L1, Wu H1, Wang X5, Chekhonin VP2,4
About authors

1 Department of Bone and Soft Tissue Tumors, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin, China

2 Department of Medicinal Nanobiotechnology, Pirogov Russian National Research Medical University, Moscow

3 Federal Medical and Biological Agency, Moscow

4 Department of Basic and Applied Neurobiology, Federal Medical Research Center for Psychiatry and Narcology, Moscow

5 Department of Epidemiology and Biostatistics, First Affiliated Hospital, Army Medical University, Chongqing, China

6 Vavilov Institute of General Genetics Russian Academy of Sciences, Moscow

Correspondеnce should be adressed: Chao Zhang
Huanhu Xi Road, Hexi Area, Tianjin, 300060, China; nc.ude.umt@oahcgnahzrd; gro.noitadnuofoa@sdrahcir.ffoeg

About paper

Funding: the present study was sponsored by China Scholarship Council (201406940004), and Russian Scientific Foundation (16–15–10432).

Received: 2018-08-26 Accepted: 2018-09-25 Published online: 2018-12-31
|
  1. Ning GZ, Yu TQ, Feng SQ, Zhou XH, Ban DX, Liu Y et al. Epidemiology of traumatic spinal cord injury in Tianjin, China. Spinal Cord. 2011; (49): 386–90.
  2. Furlan JC, Sakakibara BM, Miller WC, Krassioukov AV. Global incidence and prevalence of traumatic spinal cord injury. Can J Neurol Sci. 2014; (40): 456–64.
  3. Oliveri RS, Bello S, Biering-Sørensen F. Mesenchymal stem cells improve locomotor recovery in traumatic spinal cord injury: systematic review with meta-analyses of rat models. Neurobiol Dis. 2014; (62): 338–53.
  4. Devivo M. Epidemiology of traumatic spinal cord injury: Trends and future implications. Spinal Cord. 2012; (50): 365–72.
  5. Siddiqui AM, Khazaei M, Fehlings MG. Translating mechanisms of neuroprotection, regeneration, and repair to treatment of spinal cord injury. Prog Brain Res. 2015; (218): 15–54.
  6. Salewski RP, Mitchell RA, Li L, Shen C, Milekovskaia M, Nagy A et al. Transplantation of Induced Pluripotent Stem Cell-Derived Neural Stem Cells Mediate Functional Recovery Following Thoracic Spinal Cord Injury Through Remyelination of Axons. Stem Cells Transl Med. 2015; (4): 743–54.
  7. Raspa A, Pugliese R, Maleki M, Gelain F. Recent therapeutic approaches for spinal cord injury. Biotechnol Bioeng. 2016; (113): 253–9.
  8. Boido M, Garbossa D, Fontanella M, Ducati A, Vercelli A. Mesenchymal stem cell transplantation reduces glial cyst and improves functional outcome after spinal cord compression. World Neurosurg. 2014; (81): 183–90.
  9. Caplan AI. Mesenchymal stem cells. J Orthop Res. 1991; (9): 641–50.
  10. U.S. National Institutes of Health. Clinical trials. Available from: https://clinicaltrials.gov/.
  11. de Almeida FM, Marques SA, Ramalho Bdos S, Massoto TB, Martinez AM. Chronic spinal cord lesions respond positively to tranplants of mesenchymal stem cells. Restor Neurol Neurosci. 2015; (33): 43–55.
  12. Mendonça MV, Larocca TF, de Freitas Souza BS, Villarreal CF, Silva LF, Matos AC et al. Safety and neurological assessments after autologous transplantation of bone marrow mesenchymal stem cells in subjects with chronic spinal cord injury. Stem Cell Res Ther. 2014; (5): 126.
  13. Lee SH, Kim Y, Rhew D, Kuk M, Kim M, Kim WH et al. Effect of the combination of mesenchymal stromal cells and chondroitinase ABC on chronic spinal cord injury. Cytotherapy. 2015; (17): 1374–83.
  14. Amr SM, Gouda A, Koptan WT, Galal AA, Abdel-Fattah DS, Rashed LA et al. Bridging defects in chronic spinal cord injury using peripheral nerve grafts combined with a chitosan-laminin scaffold and enhancing regeneration through them by co-transplantation with bone-marrow-derived mesenchymal stem cells: case series of 14 patients. J Spinal Cord Med. 2014; (37): 54–71.
  15. Dai G, Liu X, Zhang Z, Yang Z, Dai Y, Xu R. Transplantation of autologous bone marrow mesenchymal stem cells in the treatment of complete and chronic cervical spinal cord injury. Brain Res. 2013; (1533): 73–9.
  16. Hodgetts SI, Simmons PJ, Plant GW. A comparison of the behavioral and anatomical outcomes in sub-acute and chronic spinal cord injury models following treatment with human mesenchymal precursor cell transplantation and recombinant decorin. Exp Neurol. 2013; (248): 343–9.
  17. Ning G, Tang L, Wu Q, Li Y, Li Y, Zhang C et al. Human umbilical cord blood stem cells for spinal cord injury: early transplantation results in better local angiogenesis. Regen Med. 2013; (8): 271–81.
  18. Takahashi Y, Tsuji O, Kumagai G, Hara CM, Okano HJ, Miyawaki A et al. Comparative study of methods for administering neural stem/ progenitor cells to treat spinal cord injury in mice. Cell Transplant. 2011; (20): 727–39.
  19. Kim JW, Ha KY, Molon JN, Kim YH. Bone marrow-derived mesenchymal stem cell transplantation for chronic spinal cord injury in rats: comparative study between intralesional and intravenous transplantation. Spine (Phila Pa 1976). 2013; (38): E1065–74.
  20. Amemori T, Jendelová P, Růzicková K, Arboleda D, Syková E. Co-transplantation of olfactory ensheathing glia and mesenchymal stromal cells does not have synergistic effects after spinal cord injury in the rat. Cytotherapy. 2010; (12): 212–25.
  21. Kang KN, Kim DY, Yoon SM, Lee JY, Lee BN, Kwon JS et al. Tissue engineered regeneration of completely transected spinal cord using human mesenchymal stem cells. Biomaterials. 2012; (33): 4828–35.
  22. Kumagai G, Tsoulfas P, Toh S, McNiece I, Bramlett HM, Dietrich WD. Genetically modified mesenchymal stem cells (MSCs) promote axonal regeneration and prevent hypersensitivity after spinal cord injury. Exp Neurol. 2013; (248): 369–80.
  23. Karamouzian S, Nematollahi-Mahani SN, Nakhaee N, Eskandary H. Clinical safety and primary efficacy of bone marrow mesenchymal cell transplantation in subacute spinal cord injured patients. Clin Neurol Neurosurg. 2012; (114): 935–9.
  24. Abakumov MA, Nukolova NV, Sokolsky-Papkov M, et al. VEGF-targeted magnetic nanoparticles for MRI visualization of brain tumor. Nanomedicine. 2015; 11 (4): 825–33.
  25. Zhang C, Morozova AY, Abakumov MA, Gubsky IL, Douglas P, Feng S et al. Precise Delivery Into Chronic Spinal Cord Injury Syringomyelic Cysts with Magnetic Nanoparticles MRI Visualization. Med Sci Monit. 2015; (21): 3179–85.
  26. Cigognini D, Satta A, Colleoni B, Silva D, Donegà M, Antonini S et al. Evaluation of early and late effects into the acute spinal cord injury of an injectable functionalized self-assembling scaffold. PLoS One. 2011; (6): e1978.
  27. Mannoji C, Koda M, Kamiya K, Dezawa M, Hashimoto M, Furuya T et al. Transplantation of human bone marrow stromal cell-derived neuroregenrative cells promotes functional recovery after spinal cord injury in mice. Acta Neurobiol Exp (Wars). 2014; (74): 479–88.
  28. Rao YJ, Zhu WX, Du ZQ, Jia CX, Du TX, Zhao QA et al. Effectiveness of olfactory ensheathing cell transplantation for treatment of spinal cord injury. Genet Mol Res. 2014; (13): 4124–9.